title: Measurement of symptom withdrawal severity in a 24-hour period after the anesthesia-assisted rapid opiate detoxification procedure.
abstract: This study examined the Anesthesia-Assisted Rapid Detoxification (AAROD) procedure and the measurement of withdrawal symptom severity within a 24-hour period. The Clinical Opiate Withdrawal Scale (COWS) was utilized at various time intervals, post detoxification. This study demonstrated that all of the patients who underwent the AAROD procedure had withdrawal symptoms post detoxification in the mild range of severity, unlike like traditional detoxification procedures. Further studies are needed to measure withdrawal symptoms longer than one-day post detoxification and to compare the differences between various detoxification protocols.
authors.affiliation: Canada Detox Centre, Richmond Hill, Ontario, Canada. dteplin@toxpro.ca
authors.forename: David
authors.initials: D
authors.lastname: Teplin
authors.forename: Barak
authors.initials: B
authors.lastname: Raz
authors.forename: Jeff
authors.initials: J
authors.lastname: Daiter
authors.forename: Michael
authors.initials: M
authors.lastname: Varenbut
authors.forename: Constantine T
authors.initials: CT
authors.lastname: Zachos
authors.forename: Paul
authors.initials: P
authors.lastname: Whang
authors.forename: Stan
authors.initials: S
authors.lastname: Herman
authors.forename: Saj
authors.initials: S
authors.lastname: Chaudry
authors.forename: Manuel
authors.initials: M
authors.lastname: Yung
mesh_terms: D000328:Adult; D018686:Anesthetics, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D002985:Clinical Protocols; D016903:Drug Monitoring / Q000379:methods*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008658:Inactivation, Metabolic; D007279:Injections, Subcutaneous; D008297:Male; D009271:Naltrexone / Q000008:administration & dosage / Q000627:therapeutic use*; D009294:Narcotics / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D015742:Propofol / Q000008:administration & dosage / Q000627:therapeutic use*; D012189:Retrospective Studies; D012720:Severity of Illness Index; D013375:Substance Withdrawal Syndrome / Q000175:diagnosis* / Q000209:etiology*; D011795:Surveys and Questionnaires
chemical_list: D018686:Anesthetics, Intravenous; D009294:Narcotics; D009271:Naltrexone; D015742:Propofol